Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_assertion type Assertion NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_head.
- NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_assertion wasGeneratedBy ECO_0000203 NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_provenance.
- NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_assertion wasDerivedFrom befree-20140225 NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_provenance.
- NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_assertion SIO_000772 22915242 NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_provenance.
- NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_assertion evidence source_evidence_literature NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_provenance.
- NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_assertion description "[We used immunohistochemistry to investigate the significance of ARID1A loss in 857 gastric carcinoma cases, including 67 EBV(+) and 136 MLH1-lost gastric carcinomas (corresponding to a microsatellite instability-high phenotype).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP181685.RALFe_dza0GJJwbwSgRn-OIeEYUBjQhnh_vnksTPaLJSs130_provenance.